Content area

Abstract

Synthetic cathinones are common constituents of abused “bath salts” preparations and represent a large family of structurally related compounds that function as cocaine-like inhibitors or amphetamine-like substrates of dopamine (DAT), norepinephrine (NET), and serotonin (SERT) transporters. Preclinical evidence suggests that some cathinones (e.g., MDPV and α-PVP) are more effective reinforcers than prototypical stimulant drugs of abuse, such as cocaine or methamphetamine. Although the reinforcing potency of these cathinones is related to their potency to inhibit DAT, less is known about the pharmacological determinants of their unusually high reinforcing effectiveness. To this end, we tested the hypothesis that reinforcing effectiveness of cathinone stimulants is positively correlated with their selectivity for DAT relative to SERT. Uptake inhibition assays in rat brain synaptosomes were used to directly compare the potency of MDPV, MDPBP, MDPPP, α-PVP, α-PPP, and cocaine at DAT, NET, and SERT, whereas intravenous self-administration in rats was used to quantify relative reinforcing effectiveness of the drugs using progressive ratio (PR) and behavioral economic procedures. All cathinones were more potent at DAT than NET or SERT, with a rank order for selectivity at DAT over SERT of α-PVP > α-PPP > MDPV > MDPBP > MDPPP > cocaine. These synthetic cathinones were more effective reinforcers than cocaine, and the measures of reinforcing effectiveness determined by PR and demand curve analyses were highly correlated with selectivity for DAT over SERT. Together, these studies provide strong and convergent evidence that the abuse potential of stimulant drugs is mediated by uptake inhibition at DAT, with activity at SERT serving as a negative modulator of reinforcing effectiveness.

Details

Title
The abuse-related effects of pyrrolidine-containing cathinones are related to their potency and selectivity to inhibit the dopamine transporter
Author
Gannon, Brenda M 1 ; Baumann, Michael H 2 ; Walther, Donna 2 ; Jimenez-Morigosa, Cristian 2 ; Sulima, Agnieszka 3 ; Rice, Kenner C 3 ; Collins, Gregory T 4 

 Department of Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA 
 Designer Drug Research Unit, Intramural Research Program, NIDA, NIH, Baltimore, MD, USA 
 Molecular Targets and Medications Discovery Branch, Intramural Research Program, NIDA and NIAAA, Bethesda, MD, USA 
 Department of Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA; South Texas Veterans Health Care System, San Antonio, TX, USA 
Pages
2399-2407
Publication year
2018
Publication date
Nov 2018
Publisher
Nature Publishing Group
ISSN
0893133X
e-ISSN
1740634X
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2117859209
Copyright
Copyright Nature Publishing Group Nov 2018